Cargando…
Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies
Polycystic ovarian syndrome (PCOS) is an heterogenous, endocrine, metabolic, and multidisciplinary disorder of reproductive-aged females that aggravates insulin resistance, hyperandrogenism, obesity, menstrual irregularities, and infertility. Bitter melon is consumed as vegetable in various parts of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536891/ https://www.ncbi.nlm.nih.gov/pubmed/36212951 http://dx.doi.org/10.1155/2022/5143653 |
_version_ | 1784803073273626624 |
---|---|
author | Hussain, Liaqat Aamir, Noor Hussain, Musaddique Asif, Muhammad Chauhdary, Zunera Manzoor, Faiza Siddique, Rida Riaz, Muhammad |
author_facet | Hussain, Liaqat Aamir, Noor Hussain, Musaddique Asif, Muhammad Chauhdary, Zunera Manzoor, Faiza Siddique, Rida Riaz, Muhammad |
author_sort | Hussain, Liaqat |
collection | PubMed |
description | Polycystic ovarian syndrome (PCOS) is an heterogenous, endocrine, metabolic, and multidisciplinary disorder of reproductive-aged females that aggravates insulin resistance, hyperandrogenism, obesity, menstrual irregularities, and infertility. Bitter melon is consumed as vegetable in various parts of the world. The purpose of this study was to provide the rationale for the folkloric uses of bitter melon (Momordica charantia L.) in reproductive abnormalities. HPLC analysis of standardized aqueous methanolic extract of bitter melon revealed the presence of various phytochemicals such as quercetin, gallic acid, benzoic acid, chlorogenic acid, syringic acid, p-coumaric acid, ferulic acid, and cinnamic acid. Twenty-five Swiss albino adult female rats (120–130 g) were acquired and divided into two groups (5 + 20). Letrozole (1 mg/kg p.o.) was used for four weeks to induce PCOS in twenty rats. Disease induction was confirmed by vaginal smear cytology analysis under the microscope. Animals were further divided into four groups, with one group as PCOS group, and the remaining three are treated with standardized extract of bitter melon (500 mg/kg p.o.), bitter melon plus metformin (500 mg/kg p.o.), and metformin alone for the period of next four weeks. After four weeks, the rats were euthanized at diestrus stage. Ovaries of the experimental animals were removed and fixed in 10% buffered formalin, and blood samples were obtained from direct cardiac puncture and stored. Ovaries histopathological analysis showed cystic follicles (9–10) in PCOS group, while, in all the treatment groups, we found developing and mature follicles. Similarly, hormone analysis showed significant (p < 0.001) reduction of LH surge, insulin, and testosterone levels and improvement in FSH levels. Lipid profile and antioxidant enzymes status were also significantly (p < 0.001) improved. In conclusion, the study validates the bitter melon potential as an insulin sensitizer and ovulation enhancer and authenticates its potential in PCOS management. |
format | Online Article Text |
id | pubmed-9536891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95368912022-10-07 Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies Hussain, Liaqat Aamir, Noor Hussain, Musaddique Asif, Muhammad Chauhdary, Zunera Manzoor, Faiza Siddique, Rida Riaz, Muhammad Evid Based Complement Alternat Med Research Article Polycystic ovarian syndrome (PCOS) is an heterogenous, endocrine, metabolic, and multidisciplinary disorder of reproductive-aged females that aggravates insulin resistance, hyperandrogenism, obesity, menstrual irregularities, and infertility. Bitter melon is consumed as vegetable in various parts of the world. The purpose of this study was to provide the rationale for the folkloric uses of bitter melon (Momordica charantia L.) in reproductive abnormalities. HPLC analysis of standardized aqueous methanolic extract of bitter melon revealed the presence of various phytochemicals such as quercetin, gallic acid, benzoic acid, chlorogenic acid, syringic acid, p-coumaric acid, ferulic acid, and cinnamic acid. Twenty-five Swiss albino adult female rats (120–130 g) were acquired and divided into two groups (5 + 20). Letrozole (1 mg/kg p.o.) was used for four weeks to induce PCOS in twenty rats. Disease induction was confirmed by vaginal smear cytology analysis under the microscope. Animals were further divided into four groups, with one group as PCOS group, and the remaining three are treated with standardized extract of bitter melon (500 mg/kg p.o.), bitter melon plus metformin (500 mg/kg p.o.), and metformin alone for the period of next four weeks. After four weeks, the rats were euthanized at diestrus stage. Ovaries of the experimental animals were removed and fixed in 10% buffered formalin, and blood samples were obtained from direct cardiac puncture and stored. Ovaries histopathological analysis showed cystic follicles (9–10) in PCOS group, while, in all the treatment groups, we found developing and mature follicles. Similarly, hormone analysis showed significant (p < 0.001) reduction of LH surge, insulin, and testosterone levels and improvement in FSH levels. Lipid profile and antioxidant enzymes status were also significantly (p < 0.001) improved. In conclusion, the study validates the bitter melon potential as an insulin sensitizer and ovulation enhancer and authenticates its potential in PCOS management. Hindawi 2022-09-29 /pmc/articles/PMC9536891/ /pubmed/36212951 http://dx.doi.org/10.1155/2022/5143653 Text en Copyright © 2022 Liaqat Hussain et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Hussain, Liaqat Aamir, Noor Hussain, Musaddique Asif, Muhammad Chauhdary, Zunera Manzoor, Faiza Siddique, Rida Riaz, Muhammad Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies |
title | Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies |
title_full | Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies |
title_fullStr | Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies |
title_full_unstemmed | Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies |
title_short | Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies |
title_sort | therapeutic investigation of standardized aqueous methanolic extract of bitter melon (momordica charantia l.) for its potential against polycystic ovarian syndrome in experimental animals' model: in vitro and in vivo studies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536891/ https://www.ncbi.nlm.nih.gov/pubmed/36212951 http://dx.doi.org/10.1155/2022/5143653 |
work_keys_str_mv | AT hussainliaqat therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies AT aamirnoor therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies AT hussainmusaddique therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies AT asifmuhammad therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies AT chauhdaryzunera therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies AT manzoorfaiza therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies AT siddiquerida therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies AT riazmuhammad therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies |